Inhibikase Therapeutics Inc. (IKT) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Inhibikase Therapeutics I...

    NASDAQ: IKT · Real-Time Price · USD
    1.55
    0.00 (0.00%)
    At close: Sep 26, 2025, 3:59 PM
    1.55
    0.00%
    After-hours: Sep 26, 2025, 04:10 PM EDT

    Inhibikase Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 56.49M 9.17M 7.19M 40.75M
    Short-Term Investments
    		 41.05M 4.09M 15.86M n/a
    Long-Term Investments
    		 n/a n/a -15.85M n/a
    Other Long-Term Assets
    		 47.1K n/a 15.85M n/a
    Receivables
    		 n/a n/a 39.88K 110.14K
    Inventory
    		 n/a n/a 1.12M 107K
    Other Current Assets
    		 826.47K 739.18K 163.45K 1.5M
    Total Current Assets
    		 98.45M 14.21M 24.37M 42.47M
    Property-Plant & Equipment
    		 101.44K 295.6K 565.17K n/a
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 148.54K 295.6K 565.17K n/a
    Total Assets
    		 98.6M 14.51M 24.94M 42.47M
    Account Payables
    		 943.02K 646.77K 1.15M 1.09M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 110.52K 381.78K 145.84K 248.91K
    Other Current Liabilities
    		 -110.52K 635.45K 1.79M n/a
    Total Current Liabilities
    		 3.73M 3.44M 3.7M 4.05M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 n/a 90.12K 205.45K 2.72M
    Total Liabilities
    		 3.73M 3.53M 3.9M 4.05M
    Total Debt
    		 110.52K 622K 351.29K 248.91K
    Book Value
    		 94.87M 10.98M 21.04M 38.42M
    Book Value Per Share
    		 4.00 2.06 5.01 12.66
    Common Stock
    		 69.36K 6.19K 25.23K 25.16K
    Retained Earnings
    		 -94.42M -66.9M -47.87M -29.82M
    Comprehensive Income
    		 -37.25K 877.00 104.72K -0.00
    Shareholders Equity
    		 94.87M 10.98M 21.04M 38.42M
    Total Investments
    		 41.05M 4.09M 15.86K n/a

    Add to Watchlist